-
1
-
-
0029134144
-
Molecular cloning and characterization of the human prostanoid DP receptor
-
Boie Y, Sawyer N, Slipetz DM, Metters KM, Abramovitz M, (1995) Molecular cloning and characterization of the human prostanoid DP receptor. The Journal of Biological Chemistry 270: 18910-18916.
-
(1995)
The Journal of Biological Chemistry
, vol.270
, pp. 18910-18916
-
-
Boie, Y.1
Sawyer, N.2
Slipetz, D.M.3
Metters, K.M.4
Abramovitz, M.5
-
2
-
-
0035862329
-
Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2
-
Hirai H, Tanaka K, Yoshie O, Ogawa K, Kenmotsu K, et al. (2001) Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2. The Journal of Experimental Medicine 193: 255-261.
-
(2001)
The Journal of Experimental Medicine
, vol.193
, pp. 255-261
-
-
Hirai, H.1
Tanaka, K.2
Yoshie, O.3
Ogawa, K.4
Kenmotsu, K.5
-
3
-
-
0025909039
-
The possible role of prostaglandin D2 in the long-lasting airways vasodilatation induced by allergen in the sensitized pig
-
Alving K, Matran R, Lundberg JM, (1991) The possible role of prostaglandin D2 in the long-lasting airways vasodilatation induced by allergen in the sensitized pig. Acta Physiologica Scandinavica 143: 93-103.
-
(1991)
Acta Physiologica Scandinavica
, vol.143
, pp. 93-103
-
-
Alving, K.1
Matran, R.2
Lundberg, J.M.3
-
4
-
-
0021141316
-
The bronchoconstrictor effect of inhaled prostaglandin D2 in normal and asthmatic men
-
Hardy CC, Robinson C, Tattersfield AE, Holgate ST, (1984) The bronchoconstrictor effect of inhaled prostaglandin D2 in normal and asthmatic men. The New England Journal of Medicine 311: 209-213.
-
(1984)
The New England Journal of Medicine
, vol.311
, pp. 209-213
-
-
Hardy, C.C.1
Robinson, C.2
Tattersfield, A.E.3
Holgate, S.T.4
-
5
-
-
0024354332
-
Effects of PGD2, PGE1, and PGI2-analogues on PGDF-release and aggregation of human gelfiltered platelets
-
Sturzebecher S, Nieuweboer B, Matthes S, Schillinger E, (1989) Effects of PGD2, PGE1, and PGI2-analogues on PGDF-release and aggregation of human gelfiltered platelets. Progress in Clinical and Biological Research 301: 365-369.
-
(1989)
Progress in Clinical and Biological Research
, vol.301
, pp. 365-369
-
-
Sturzebecher, S.1
Nieuweboer, B.2
Matthes, S.3
Schillinger, E.4
-
6
-
-
0028245181
-
Inhibition of human platelets and polymorphonuclear neutrophils by the potent and metabolically stable prostaglandin D2 analog ZK 118.182
-
Darius H, Michael-Hepp J, Thierauch KH, Fisch A, (1994) Inhibition of human platelets and polymorphonuclear neutrophils by the potent and metabolically stable prostaglandin D2 analog ZK 118.182. European Journal of Pharmacology 258: 207-213.
-
(1994)
European Journal of Pharmacology
, vol.258
, pp. 207-213
-
-
Darius, H.1
Michael-Hepp, J.2
Thierauch, K.H.3
Fisch, A.4
-
7
-
-
0022377745
-
Different responsiveness of prostaglandin D2-sensitive systems to prostaglandin D2 and its analogues
-
Narumiya S, Toda N, (1985) Different responsiveness of prostaglandin D2-sensitive systems to prostaglandin D2 and its analogues. British Journal of Pharmacology 85: 367-375.
-
(1985)
British Journal of Pharmacology
, vol.85
, pp. 367-375
-
-
Narumiya, S.1
Toda, N.2
-
8
-
-
3042705826
-
Ramatroban (BAY u 3405): A novel dual antagonist of TXA2 receptor and CRTh2, a newly identified prostaglandin D2 receptor
-
Ishizuka T, Matsui T, Okamoto Y, Ohta A, Shichijo M, (2004) Ramatroban (BAY u 3405): A novel dual antagonist of TXA2 receptor and CRTh2, a newly identified prostaglandin D2 receptor. Cardiovascular Drug Reviews 22: 71-90.
-
(2004)
Cardiovascular Drug Reviews
, vol.22
, pp. 71-90
-
-
Ishizuka, T.1
Matsui, T.2
Okamoto, Y.3
Ohta, A.4
Shichijo, M.5
-
9
-
-
0023818373
-
Prostaglandin D2 mediates the stimulation of glycogenolysis in the liver by phorbol ester
-
Casteleijn E, Kuiper J, Van Rooij HC, Kamps JA, Koster JF, et al. (1988) Prostaglandin D2 mediates the stimulation of glycogenolysis in the liver by phorbol ester. The Biochemical Journal 250: 77-80.
-
(1988)
The Biochemical Journal
, vol.250
, pp. 77-80
-
-
Casteleijn, E.1
Kuiper, J.2
Van Rooij, H.C.3
Kamps, J.A.4
Koster, J.F.5
-
10
-
-
0034677595
-
Prostaglandin D2 as a mediator of allergic asthma
-
Matsuoka T, Hirata M, Tanaka H, Takahashi Y, Murata T, et al. (2000) Prostaglandin D2 as a mediator of allergic asthma. Science (New York, N.Y.) 287: 2013-2017.
-
(2000)
Science (New York, N.Y.)
, vol.287
, pp. 2013-2017
-
-
Matsuoka, T.1
Hirata, M.2
Tanaka, H.3
Takahashi, Y.4
Murata, T.5
-
11
-
-
0042623534
-
The DP receptor, allergic inflammation and asthma
-
Kabashima K, Narumiya S, (2003) The DP receptor, allergic inflammation and asthma. Prostaglandins, Leukotrienes, and Essential Fatty Acids 69: 187-194.
-
(2003)
Prostaglandins, Leukotrienes, and Essential Fatty Acids
, vol.69
, pp. 187-194
-
-
Kabashima, K.1
Narumiya, S.2
-
12
-
-
0038138607
-
The second PGD(2) receptor CRTH2: Structure, properties, and functions in leukocytes
-
Nagata K, Hirai H, (2003) The second PGD(2) receptor CRTH2: Structure, properties, and functions in leukocytes. Prostaglandins, Leukotrienes, and Essential Fatty Acids 69: 169-177.
-
(2003)
Prostaglandins, Leukotrienes, and Essential Fatty Acids
, vol.69
, pp. 169-177
-
-
Nagata, K.1
Hirai, H.2
-
13
-
-
0028985630
-
Selective prostaglandin D2 receptor stimulation elicits ocular hypotensive effects in rabbits and cats
-
Matsugi T, Kageyama M, Nishimura K, Giles H, Shirasawa E, (1995) Selective prostaglandin D2 receptor stimulation elicits ocular hypotensive effects in rabbits and cats. European Journal of Pharmacology 275: 245-250.
-
(1995)
European Journal of Pharmacology
, vol.275
, pp. 245-250
-
-
Matsugi, T.1
Kageyama, M.2
Nishimura, K.3
Giles, H.4
Shirasawa, E.5
-
15
-
-
0021823255
-
Studies on the mechanism of central cardiovascular and temperature responses to prostaglandin D2
-
Forstermann U, Heldt R, Hertting G, (1985) Studies on the mechanism of central cardiovascular and temperature responses to prostaglandin D2. Prostaglandins, Leukotrienes, and Medicine 18: 301-308.
-
(1985)
Prostaglandins, Leukotrienes, and Medicine
, vol.18
, pp. 301-308
-
-
Forstermann, U.1
Heldt, R.2
Hertting, G.3
-
16
-
-
76849108780
-
Prostanoid DP receptor (PTGDR) variants in mothers with post-coital associated preterm births: Preliminary observations
-
Grisaru-Granovsky S, Altarescu G, Finci S, Weintraub A, Tevet A, et al. (2010) Prostanoid DP receptor (PTGDR) variants in mothers with post-coital associated preterm births: Preliminary observations. Journal of Perinatology: Official Journal of the California Perinatal Association 30: 33-37.
-
(2010)
Journal of Perinatology: Official Journal of the California Perinatal Association
, vol.30
, pp. 33-37
-
-
Grisaru-Granovsky, S.1
Altarescu, G.2
Finci, S.3
Weintraub, A.4
Tevet, A.5
-
17
-
-
15344348453
-
Production of prostaglandin D(2) by human osteoblasts and modulation of osteoprotegerin, RANKL, and cellular migration by DP and CRTH2 receptors
-
Gallant MA, Samadfam R, Hackett JA, Antoniou J, Parent JL, et al. (2005) Production of prostaglandin D(2) by human osteoblasts and modulation of osteoprotegerin, RANKL, and cellular migration by DP and CRTH2 receptors. Journal of Bone and Mineral Research: The Official Journal of the American Society for Bone and Mineral Research 20: 672-681.
-
(2005)
Journal of Bone and Mineral Research: The Official Journal of the American Society for Bone and Mineral Research
, vol.20
, pp. 672-681
-
-
Gallant, M.A.1
Samadfam, R.2
Hackett, J.A.3
Antoniou, J.4
Parent, J.L.5
-
19
-
-
77949663899
-
Increased concentrations of prostaglandin D2 during post-fracture bone remodeling
-
Gallant MA, Chamoux E, Bisson M, Wolsen C, Parent JL, et al. (2010) Increased concentrations of prostaglandin D2 during post-fracture bone remodeling. The Journal of Rheumatology 37: 644-649.
-
(2010)
The Journal of Rheumatology
, vol.37
, pp. 644-649
-
-
Gallant, M.A.1
Chamoux, E.2
Bisson, M.3
Wolsen, C.4
Parent, J.L.5
-
20
-
-
84862701957
-
Prostaglandin D2 induces apoptosis of human osteoclasts by activating the CRTH2 receptor and the intrinsic apoptosis pathway
-
Yue L, Durand M, Lebeau Jacob MC, Hogan P, McManus S, et al. (2012) Prostaglandin D2 induces apoptosis of human osteoclasts by activating the CRTH2 receptor and the intrinsic apoptosis pathway. Bone 51: 338-346.
-
(2012)
Bone
, vol.51
, pp. 338-346
-
-
Yue, L.1
Durand, M.2
Lebeau Jacob, M.C.3
Hogan, P.4
McManus, S.5
-
21
-
-
33750178069
-
Prostaglandin D2 induces IL-8 and GM-CSF by bronchial epithelial cells in a CRTH2-independent pathway
-
Chiba T, Kanda A, Ueki S, Ito W, Kamada Y, et al. (2006) Prostaglandin D2 induces IL-8 and GM-CSF by bronchial epithelial cells in a CRTH2-independent pathway. International Archives of Allergy and Immunology 141: 300-307.
-
(2006)
International Archives of Allergy and Immunology
, vol.141
, pp. 300-307
-
-
Chiba, T.1
Kanda, A.2
Ueki, S.3
Ito, W.4
Kamada, Y.5
-
22
-
-
0036944934
-
Molecular pharmacology of the human prostaglandin D2 receptor, CRTH2
-
Sawyer N, Cauchon E, Chateauneuf A, Cruz RP, Nicholson DW, et al. (2002) Molecular pharmacology of the human prostaglandin D2 receptor, CRTH2. British Journal of Pharmacology 137: 1163-1172.
-
(2002)
British Journal of Pharmacology
, vol.137
, pp. 1163-1172
-
-
Sawyer, N.1
Cauchon, E.2
Chateauneuf, A.3
Cruz, R.P.4
Nicholson, D.W.5
-
23
-
-
69249211014
-
Prostanoid receptor antagonists: Development strategies and therapeutic applications
-
Jones RL, Giembycz MA, Woodward DF, (2009) Prostanoid receptor antagonists: Development strategies and therapeutic applications. British Journal of Pharmacology 158: 104-145.
-
(2009)
British Journal of Pharmacology
, vol.158
, pp. 104-145
-
-
Jones, R.L.1
Giembycz, M.A.2
Woodward, D.F.3
-
24
-
-
0034012172
-
Affinities, selectivities, potencies, and intrinsic activities of natural and synthetic prostanoids using endogenous receptors: Focus on DP class prostanoids
-
Sharif NA, Crider JY, Xu SX, Williams GW, (2000) Affinities, selectivities, potencies, and intrinsic activities of natural and synthetic prostanoids using endogenous receptors: Focus on DP class prostanoids. The Journal of Pharmacology and Experimental Therapeutics 293: 321-328.
-
(2000)
The Journal of Pharmacology and Experimental Therapeutics
, vol.293
, pp. 321-328
-
-
Sharif, N.A.1
Crider, J.Y.2
Xu, S.X.3
Williams, G.W.4
-
25
-
-
0032903864
-
Prostaglandin DP receptors positively coupled to adenylyl cyclase in embryonic bovine tracheal (EBTr) cells: Pharmacological characterization using agonists and antagonists
-
Crider JY, Griffin BW, Sharif NA, (1999) Prostaglandin DP receptors positively coupled to adenylyl cyclase in embryonic bovine tracheal (EBTr) cells: Pharmacological characterization using agonists and antagonists. British Journal of Pharmacology 127: 204-210.
-
(1999)
British Journal of Pharmacology
, vol.127
, pp. 204-210
-
-
Crider, J.Y.1
Griffin, B.W.2
Sharif, N.A.3
-
26
-
-
0024477713
-
Antagonism of PGD2 vasodepressor responses in the rat in vivo by the novel, selective antagonist, BW A868C
-
Hamid-Bloomfield S, Whittle BJ, (1989) Antagonism of PGD2 vasodepressor responses in the rat in vivo by the novel, selective antagonist, BW A868C. British Journal of Pharmacology 96: 307-312.
-
(1989)
British Journal of Pharmacology
, vol.96
, pp. 307-312
-
-
Hamid-Bloomfield, S.1
Whittle, B.J.2
-
27
-
-
33847345910
-
Discovery of a potent and selective prostaglandin D2 receptor antagonist, [(3R)-4-(4-chloro-benzyl)-7-fluoro-5-(methylsulfonyl)-1,2,3,4-tetrahydrocyclopent a[b]indol-3-yl]-acetic acid (MK-0524)
-
Sturino CF, O'Neill G, Lachance N, Boyd M, Berthelette C, et al. (2007) Discovery of a potent and selective prostaglandin D2 receptor antagonist, [(3R)-4-(4-chloro-benzyl)-7-fluoro-5-(methylsulfonyl)-1,2,3,4-tetrahydrocyclopent a[b]indol-3-yl]-acetic acid (MK-0524). Journal of Medicinal Chemistry 50: 794-806.
-
(2007)
Journal of Medicinal Chemistry
, vol.50
, pp. 794-806
-
-
Sturino, C.F.1
O'Neill, G.2
Lachance, N.3
Boyd, M.4
Berthelette, C.5
-
28
-
-
34249024864
-
Suppression of niacin-induced vasodilation with an antagonist to prostaglandin D2 receptor subtype 1
-
Lai E, De Lepeleire I, Crumley TM, Liu F, Wenning LA, et al. (2007) Suppression of niacin-induced vasodilation with an antagonist to prostaglandin D2 receptor subtype 1. Clinical Pharmacology and Therapeutics 81: 849-857.
-
(2007)
Clinical Pharmacology and Therapeutics
, vol.81
, pp. 849-857
-
-
Lai, E.1
De Lepeleire, I.2
Crumley, T.M.3
Liu, F.4
Wenning, L.A.5
-
30
-
-
0345735773
-
Agonist and inverse agonist actions of beta-blockers at the human beta 2-adrenoceptor provide evidence for agonist-directed signaling
-
Baker JG, Hall IP, Hill SJ, (2003) Agonist and inverse agonist actions of beta-blockers at the human beta 2-adrenoceptor provide evidence for agonist-directed signaling. Molecular Pharmacology 64: 1357-1369.
-
(2003)
Molecular Pharmacology
, vol.64
, pp. 1357-1369
-
-
Baker, J.G.1
Hall, I.P.2
Hill, S.J.3
-
31
-
-
0141702358
-
Protean agonism at histamine H3 receptors in vitro and in vivo
-
Gbahou F, Rouleau A, Morisset S, Parmentier R, Crochet S, et al. (2003) Protean agonism at histamine H3 receptors in vitro and in vivo. Proceedings of the National Academy of Sciences of the United States of America 100: 11086-11091.
-
(2003)
Proceedings of the National Academy of Sciences of the United States of America
, vol.100
, pp. 11086-11091
-
-
Gbahou, F.1
Rouleau, A.2
Morisset, S.3
Parmentier, R.4
Crochet, S.5
-
32
-
-
14844333116
-
Internalization and src activity regulate the time course of ERK activation by delta opioid receptor ligands
-
Audet N, Paquin-Gobeil M, Landry-Paquet O, Schiller PW, Pineyro G, (2005) Internalization and src activity regulate the time course of ERK activation by delta opioid receptor ligands. The Journal of Biological Chemistry 280: 7808-7816.
-
(2005)
The Journal of Biological Chemistry
, vol.280
, pp. 7808-7816
-
-
Audet, N.1
Paquin-Gobeil, M.2
Landry-Paquet, O.3
Schiller, P.W.4
Pineyro, G.5
-
33
-
-
20744434986
-
Characterization of serotonin 5-HT2C receptor signaling to extracellular signal-regulated kinases 1 and 2
-
Werry TD, Gregory KJ, Sexton PM, Christopoulos A, (2005) Characterization of serotonin 5-HT2C receptor signaling to extracellular signal-regulated kinases 1 and 2. Journal of Neurochemistry 93: 1603-1615.
-
(2005)
Journal of Neurochemistry
, vol.93
, pp. 1603-1615
-
-
Werry, T.D.1
Gregory, K.J.2
Sexton, P.M.3
Christopoulos, A.4
-
34
-
-
0042887023
-
Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology
-
Shapiro DA, Renock S, Arrington E, Chiodo LA, Liu LX, et al. (2003) Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 28: 1400-1411.
-
(2003)
Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology
, vol.28
, pp. 1400-1411
-
-
Shapiro, D.A.1
Renock, S.2
Arrington, E.3
Chiodo, L.A.4
Liu, L.X.5
-
35
-
-
31844446495
-
Recent developments in constitutive receptor activity and inverse agonism, and their potential for GPCR drug discovery
-
Bond RA, Ijzerman AP, (2006) Recent developments in constitutive receptor activity and inverse agonism, and their potential for GPCR drug discovery. Trends in Pharmacological Sciences 27: 92-96.
-
(2006)
Trends in Pharmacological Sciences
, vol.27
, pp. 92-96
-
-
Bond, R.A.1
Ijzerman, A.P.2
-
36
-
-
0030823303
-
A three-state receptor model of agonist action
-
Leff P, Scaramellini C, Law C, McKechnie K, (1997) A three-state receptor model of agonist action. Trends in Pharmacological Sciences 18: 355-362.
-
(1997)
Trends in Pharmacological Sciences
, vol.18
, pp. 355-362
-
-
Leff, P.1
Scaramellini, C.2
Law, C.3
McKechnie, K.4
-
37
-
-
22944487986
-
Multiple signaling states of G-protein-coupled receptors
-
Perez DM, Karnik SS, (2005) Multiple signaling states of G-protein-coupled receptors. Pharmacological Reviews 57: 147-161.
-
(2005)
Pharmacological Reviews
, vol.57
, pp. 147-161
-
-
Perez, D.M.1
Karnik, S.S.2
-
38
-
-
33846020543
-
Small molecule pharmacological chaperones: From thermodynamic stabilization to pharmaceutical drugs
-
Arakawa T, Ejima D, Kita Y, Tsumoto K, (2006) Small molecule pharmacological chaperones: From thermodynamic stabilization to pharmaceutical drugs. Biochimica Et Biophysica Acta 1764: 1677-1687.
-
(2006)
Biochimica Et Biophysica Acta
, vol.1764
, pp. 1677-1687
-
-
Arakawa, T.1
Ejima, D.2
Kita, Y.3
Tsumoto, K.4
-
39
-
-
7244253015
-
Pharmacologic rescue of conformationally-defective proteins: Implications for the treatment of human disease
-
Ulloa-Aguirre A, Janovick JA, Brothers SP, Conn PM, (2004) Pharmacologic rescue of conformationally-defective proteins: Implications for the treatment of human disease. Traffic (Copenhagen, Denmark) 5: 821-837.
-
(2004)
Traffic (Copenhagen, Denmark)
, vol.5
, pp. 821-837
-
-
Ulloa-Aguirre, A.1
Janovick, J.A.2
Brothers, S.P.3
Conn, P.M.4
-
40
-
-
3442880434
-
Functional rescue of the constitutively internalized V2 vasopressin receptor mutant R137H by the pharmacological chaperone action of SR49059
-
Bernier V, Lagace M, Lonergan M, Arthus MF, Bichet DG, et al. (2004) Functional rescue of the constitutively internalized V2 vasopressin receptor mutant R137H by the pharmacological chaperone action of SR49059. Molecular Endocrinology (Baltimore, Md.) 18: 2074-2084.
-
(2004)
Molecular Endocrinology (Baltimore, Md.)
, vol.18
, pp. 2074-2084
-
-
Bernier, V.1
Lagace, M.2
Lonergan, M.3
Arthus, M.F.4
Bichet, D.G.5
-
41
-
-
0036322898
-
Rescue of hypogonadotropic hypogonadism-causing and manufactured GnRH receptor mutants by a specific protein-folding template: Misrouted proteins as a novel disease etiology and therapeutic target
-
Janovick JA, Maya-Nunez G, Conn PM, (2002) Rescue of hypogonadotropic hypogonadism-causing and manufactured GnRH receptor mutants by a specific protein-folding template: Misrouted proteins as a novel disease etiology and therapeutic target. The Journal of Clinical Endocrinology and Metabolism 87: 3255-3262.
-
(2002)
The Journal of Clinical Endocrinology and Metabolism
, vol.87
, pp. 3255-3262
-
-
Janovick, J.A.1
Maya-Nunez, G.2
Conn, P.M.3
-
42
-
-
78650312810
-
ANKRD13C acts as a molecular chaperone for G protein-coupled receptors
-
Parent A, Roy SJ, Iorio-Morin C, Lepine MC, Labrecque P, et al. (2010) ANKRD13C acts as a molecular chaperone for G protein-coupled receptors. The Journal of Biological Chemistry 285: 40838-40851.
-
(2010)
The Journal of Biological Chemistry
, vol.285
, pp. 40838-40851
-
-
Parent, A.1
Roy, S.J.2
Iorio-Morin, C.3
Lepine, M.C.4
Labrecque, P.5
-
43
-
-
33846849199
-
Differential regulation of the signaling and trafficking of the two prostaglandin D2 receptors, prostanoid DP receptor and CRTH2
-
Gallant MA, Slipetz D, Hamelin E, Rochdi MD, Talbot S, et al. (2007) Differential regulation of the signaling and trafficking of the two prostaglandin D2 receptors, prostanoid DP receptor and CRTH2. European Journal of Pharmacology 557: 115-123.
-
(2007)
European Journal of Pharmacology
, vol.557
, pp. 115-123
-
-
Gallant, M.A.1
Slipetz, D.2
Hamelin, E.3
Rochdi, M.D.4
Talbot, S.5
-
44
-
-
0030006864
-
Identification of prostanoid receptors in rabbit non-pigmented ciliary epithelial cells
-
Bhattacherjee P, Jacobs N, Coca-Prados M, Paterson C, (1996) Identification of prostanoid receptors in rabbit non-pigmented ciliary epithelial cells. Experimental Eye Research 62: 491-498.
-
(1996)
Experimental Eye Research
, vol.62
, pp. 491-498
-
-
Bhattacherjee, P.1
Jacobs, N.2
Coca-Prados, M.3
Paterson, C.4
-
45
-
-
0024547972
-
The classification of prostaglandin DP-receptors in platelets and vasculature using BW A868C, a novel, selective and potent competitive antagonist
-
Giles H, Leff P, Bolofo ML, Kelly MG, Robertson AD, (1989) The classification of prostaglandin DP-receptors in platelets and vasculature using BW A868C, a novel, selective and potent competitive antagonist. British Journal of Pharmacology 96: 291-300.
-
(1989)
British Journal of Pharmacology
, vol.96
, pp. 291-300
-
-
Giles, H.1
Leff, P.2
Bolofo, M.L.3
Kelly, M.G.4
Robertson, A.D.5
-
46
-
-
0027974137
-
Molecular characterization of a mouse prostaglandin D receptor and functional expression of the cloned gene
-
Hirata M, Kakizuka A, Aizawa M, Ushikubi F, Narumiya S, (1994) Molecular characterization of a mouse prostaglandin D receptor and functional expression of the cloned gene. Proceedings of the National Academy of Sciences of the United States of America 91: 11192-11196.
-
(1994)
Proceedings of the National Academy of Sciences of the United States of America
, vol.91
, pp. 11192-11196
-
-
Hirata, M.1
Kakizuka, A.2
Aizawa, M.3
Ushikubi, F.4
Narumiya, S.5
-
47
-
-
0031913845
-
Characterization of the recombinant human prostanoid DP receptor and identification of L-644,698, a novel selective DP agonist
-
Wright DH, Metters KM, Abramovitz M, Ford-Hutchinson AW, (1998) Characterization of the recombinant human prostanoid DP receptor and identification of L-644,698, a novel selective DP agonist. British Journal of Pharmacology 123: 1317-1324.
-
(1998)
British Journal of Pharmacology
, vol.123
, pp. 1317-1324
-
-
Wright, D.H.1
Metters, K.M.2
Abramovitz, M.3
Ford-Hutchinson, A.W.4
-
48
-
-
0030598636
-
Partial agonist effects of BW A868C, a selective DP receptor antagonist, on cl- secretion in dog tracheal epithelium
-
Liu YJ, Jackson DM, Blackham A, Leff P, (1996) Partial agonist effects of BW A868C, a selective DP receptor antagonist, on cl- secretion in dog tracheal epithelium. European Journal of Pharmacology 304: 117-122.
-
(1996)
European Journal of Pharmacology
, vol.304
, pp. 117-122
-
-
Liu, Y.J.1
Jackson, D.M.2
Blackham, A.3
Leff, P.4
-
49
-
-
0033605423
-
Internalization of the TXA2 receptor alpha and beta isoforms. role of the differentially spliced cooh terminus in agonist-promoted receptor internalization
-
Parent JL, Labrecque P, Orsini MJ, Benovic JL, (1999) Internalization of the TXA2 receptor alpha and beta isoforms. role of the differentially spliced cooh terminus in agonist-promoted receptor internalization. The Journal of Biological Chemistry 274: 8941-8948.
-
(1999)
The Journal of Biological Chemistry
, vol.274
, pp. 8941-8948
-
-
Parent, J.L.1
Labrecque, P.2
Orsini, M.J.3
Benovic, J.L.4
-
50
-
-
77649190267
-
Characterization of C-terminal tail determinants involved in CRTH2 receptor trafficking: Identification of a recycling motif
-
Roy SJ, Parent A, Gallant MA, de Brum-Fernandes AJ, Stankova J, et al. (2010) Characterization of C-terminal tail determinants involved in CRTH2 receptor trafficking: Identification of a recycling motif. European Journal of Pharmacology 630: 10-18.
-
(2010)
European Journal of Pharmacology
, vol.630
, pp. 10-18
-
-
Roy, S.J.1
Parent, A.2
Gallant, M.A.3
de Brum-Fernandes, A.J.4
Stankova, J.5
-
51
-
-
27744469168
-
The intracellular trafficking of the G protein-coupled receptor TPbeta depends on a direct interaction with Rab11
-
Hamelin E, Theriault C, Laroche G, Parent JL, (2005) The intracellular trafficking of the G protein-coupled receptor TPbeta depends on a direct interaction with Rab11. The Journal of Biological Chemistry 280: 36195-36205.
-
(2005)
The Journal of Biological Chemistry
, vol.280
, pp. 36195-36205
-
-
Hamelin, E.1
Theriault, C.2
Laroche, G.3
Parent, J.L.4
-
52
-
-
0035831509
-
Role of the differentially spliced carboxyl terminus in thromboxane A2 receptor trafficking: Identification of a distinct motif for tonic internalization
-
Parent JL, Labrecque P, Driss Rochdi M, Benovic JL, (2001) Role of the differentially spliced carboxyl terminus in thromboxane A2 receptor trafficking: Identification of a distinct motif for tonic internalization. The Journal of Biological Chemistry 276: 7079-7085.
-
(2001)
The Journal of Biological Chemistry
, vol.276
, pp. 7079-7085
-
-
Parent, J.L.1
Labrecque, P.2
Driss Rochdi, M.3
Benovic, J.L.4
-
53
-
-
0347627709
-
Constitutive activity and inverse agonists of G protein-coupled receptors: A current perspective
-
Milligan G, (2003) Constitutive activity and inverse agonists of G protein-coupled receptors: A current perspective. Molecular Pharmacology 64: 1271-1276.
-
(2003)
Molecular Pharmacology
, vol.64
, pp. 1271-1276
-
-
Milligan, G.1
-
57
-
-
33751162165
-
Distinct signaling profiles of beta1 and beta2 adrenergic receptor ligands toward adenylyl cyclase and mitogen-activated protein kinase reveals the pluridimensionality of efficacy
-
Galandrin S, Bouvier M, (2006) Distinct signaling profiles of beta1 and beta2 adrenergic receptor ligands toward adenylyl cyclase and mitogen-activated protein kinase reveals the pluridimensionality of efficacy. Molecular Pharmacology 70: 1575-1584.
-
(2006)
Molecular Pharmacology
, vol.70
, pp. 1575-1584
-
-
Galandrin, S.1
Bouvier, M.2
-
58
-
-
33845316454
-
The V2 vasopressin receptor stimulates ERK1/2 activity independently of heterotrimeric G protein signalling
-
Charest PG, Oligny-Longpre G, Bonin H, Azzi M, Bouvier M, (2007) The V2 vasopressin receptor stimulates ERK1/2 activity independently of heterotrimeric G protein signalling. Cellular Signalling 19: 32-41.
-
(2007)
Cellular Signalling
, vol.19
, pp. 32-41
-
-
Charest, P.G.1
Oligny-Longpre, G.2
Bonin, H.3
Azzi, M.4
Bouvier, M.5
-
59
-
-
0035816704
-
Functionally different agonists induce distinct conformations in the G protein coupling domain of the beta 2 adrenergic receptor
-
Ghanouni P, Gryczynski Z, Steenhuis JJ, Lee TW, Farrens DL, et al. (2001) Functionally different agonists induce distinct conformations in the G protein coupling domain of the beta 2 adrenergic receptor. The Journal of Biological Chemistry 276: 24433-24436.
-
(2001)
The Journal of Biological Chemistry
, vol.276
, pp. 24433-24436
-
-
Ghanouni, P.1
Gryczynski, Z.2
Steenhuis, J.J.3
Lee, T.W.4
Farrens, D.L.5
-
60
-
-
34447650979
-
Versatility of GPCR recognition by drugs: From biological implications to therapeutic relevance
-
Bosier B, Hermans E, (2007) Versatility of GPCR recognition by drugs: From biological implications to therapeutic relevance. Trends in Pharmacological Sciences 28: 438-446.
-
(2007)
Trends in Pharmacological Sciences
, vol.28
, pp. 438-446
-
-
Bosier, B.1
Hermans, E.2
-
61
-
-
77952354490
-
Seven transmembrane receptors as shapeshifting proteins: The impact of allosteric modulation and functional selectivity on new drug discovery
-
Kenakin T, Miller LJ, (2010) Seven transmembrane receptors as shapeshifting proteins: The impact of allosteric modulation and functional selectivity on new drug discovery. Pharmacological Reviews 62: 265-304.
-
(2010)
Pharmacological Reviews
, vol.62
, pp. 265-304
-
-
Kenakin, T.1
Miller, L.J.2
-
63
-
-
33846909764
-
"Phenotypic" pharmacology: The influence of cellular environment on G protein-coupled receptor antagonist and inverse agonist pharmacology
-
Nelson CP, Challiss RA, (2007) "Phenotypic" pharmacology: The influence of cellular environment on G protein-coupled receptor antagonist and inverse agonist pharmacology. Biochemical Pharmacology 73: 737-751.
-
(2007)
Biochemical Pharmacology
, vol.73
, pp. 737-751
-
-
Nelson, C.P.1
Challiss, R.A.2
-
64
-
-
33947259630
-
Inverse agonism: From curiosity to accepted dogma, but is it clinically relevant?
-
Parra S, Bond RA, (2007) Inverse agonism: From curiosity to accepted dogma, but is it clinically relevant? Current Opinion in Pharmacology 7: 146-150.
-
(2007)
Current Opinion in Pharmacology
, vol.7
, pp. 146-150
-
-
Parra, S.1
Bond, R.A.2
-
65
-
-
33751284236
-
Inverse agonism or neutral antagonism at G-protein coupled receptors: A medicinal chemistry challenge worth pursuing?
-
Greasley PJ, Clapham JC, (2006) Inverse agonism or neutral antagonism at G-protein coupled receptors: A medicinal chemistry challenge worth pursuing? European Journal of Pharmacology 553: 1-9.
-
(2006)
European Journal of Pharmacology
, vol.553
, pp. 1-9
-
-
Greasley, P.J.1
Clapham, J.C.2
-
66
-
-
1642495639
-
Efficacy as a vector: The relative prevalence and paucity of inverse agonism
-
Kenakin T, (2004) Efficacy as a vector: The relative prevalence and paucity of inverse agonism. Molecular Pharmacology 65: 2-11.
-
(2004)
Molecular Pharmacology
, vol.65
, pp. 2-11
-
-
Kenakin, T.1
-
67
-
-
0036010766
-
H1-antihistamines: Inverse agonism, anti-inflammatory actions and cardiac effects
-
Leurs R, Church MK, Taglialatela M, (2002) H1-antihistamines: Inverse agonism, anti-inflammatory actions and cardiac effects. Clinical and Experimental Allergy: Journal of the British Society for Allergy and Clinical Immunology 32: 489-498.
-
(2002)
Clinical and Experimental Allergy: Journal of the British Society for Allergy and Clinical Immunology
, vol.32
, pp. 489-498
-
-
Leurs, R.1
Church, M.K.2
Taglialatela, M.3
-
68
-
-
0024597277
-
The antagonism by BW A868C of PGD2 and BW245C activation of human platelet adenylate cyclase
-
Trist DG, Collins BA, Wood J, Kelly MG, Robertson AD, (1989) The antagonism by BW A868C of PGD2 and BW245C activation of human platelet adenylate cyclase. British Journal of Pharmacology 96: 301-306.
-
(1989)
British Journal of Pharmacology
, vol.96
, pp. 301-306
-
-
Trist, D.G.1
Collins, B.A.2
Wood, J.3
Kelly, M.G.4
Robertson, A.D.5
-
69
-
-
78951492322
-
An interaction between L-prostaglandin D synthase and arrestin increases PGD2 production
-
Mathurin K, Gallant MA, Germain P, Allard-Chamard H, Brisson J, et al. (2011) An interaction between L-prostaglandin D synthase and arrestin increases PGD2 production. The Journal of Biological Chemistry 286: 2696-2706.
-
(2011)
The Journal of Biological Chemistry
, vol.286
, pp. 2696-2706
-
-
Mathurin, K.1
Gallant, M.A.2
Germain, P.3
Allard-Chamard, H.4
Brisson, J.5
-
70
-
-
0029816971
-
Inverse agonism of amino-terminally truncated parathyroid hormone (PTH) and PTH-related peptide (PTHrP) analogs revealed with constitutively active mutant PTH/PTHrP receptors
-
Gardella TJ, Luck MD, Jensen GS, Schipani E, Potts JT, Jr, et al, (1996) Inverse agonism of amino-terminally truncated parathyroid hormone (PTH) and PTH-related peptide (PTHrP) analogs revealed with constitutively active mutant PTH/PTHrP receptors. Endocrinology 137: 3936-3941.
-
(1996)
Endocrinology
, vol.137
, pp. 3936-3941
-
-
Gardella, T.J.1
Luck, M.D.2
Jensen, G.S.3
Schipani, E.4
Potts Jr., J.T.5
-
71
-
-
77952415656
-
Beyond desensitization: Physiological relevance of arrestin-dependent signaling
-
Luttrell LM, Gesty-Palmer D, (2010) Beyond desensitization: Physiological relevance of arrestin-dependent signaling. Pharmacological Reviews 62: 305-330.
-
(2010)
Pharmacological Reviews
, vol.62
, pp. 305-330
-
-
Luttrell, L.M.1
Gesty-Palmer, D.2
-
72
-
-
2542484525
-
Ligand-selective dissociation of activation and internalization of the parathyroid hormone (PTH) receptor: Conditional efficacy of PTH peptide fragments
-
Sneddon WB, Magyar CE, Willick GE, Syme CA, Galbiati F, et al. (2004) Ligand-selective dissociation of activation and internalization of the parathyroid hormone (PTH) receptor: Conditional efficacy of PTH peptide fragments. Endocrinology 145: 2815-2823.
-
(2004)
Endocrinology
, vol.145
, pp. 2815-2823
-
-
Sneddon, W.B.1
Magyar, C.E.2
Willick, G.E.3
Syme, C.A.4
Galbiati, F.5
-
74
-
-
0033621812
-
Interaction with gbetagamma is required for membrane targeting and palmitoylation of galpha(s) and galpha(q)
-
Evanko DS, Thiyagarajan MM, Wedegaertner PB, (2000) Interaction with gbetagamma is required for membrane targeting and palmitoylation of galpha(s) and galpha(q). The Journal of Biological Chemistry 275: 1327-1336.
-
(2000)
The Journal of Biological Chemistry
, vol.275
, pp. 1327-1336
-
-
Evanko, D.S.1
Thiyagarajan, M.M.2
Wedegaertner, P.B.3
-
75
-
-
0035830863
-
Newly synthesized human delta opioid receptors retained in the endoplasmic reticulum are retrotranslocated to the cytosol, deglycosylated, ubiquitinated, and degraded by the proteasome
-
Petaja-Repo UE, Hogue M, Laperriere A, Bhalla S, Walker P, et al. (2001) Newly synthesized human delta opioid receptors retained in the endoplasmic reticulum are retrotranslocated to the cytosol, deglycosylated, ubiquitinated, and degraded by the proteasome. The Journal of Biological Chemistry 276: 4416-4423.
-
(2001)
The Journal of Biological Chemistry
, vol.276
, pp. 4416-4423
-
-
Petaja-Repo, U.E.1
Hogue, M.2
Laperriere, A.3
Bhalla, S.4
Walker, P.5
-
76
-
-
0037007201
-
Ligands act as pharmacological chaperones and increase the efficiency of delta opioid receptor maturation
-
Petaja-Repo UE, Hogue M, Bhalla S, Laperriere A, Morello JP, et al. (2002) Ligands act as pharmacological chaperones and increase the efficiency of delta opioid receptor maturation. The EMBO Journal 21: 1628-1637.
-
(2002)
The EMBO Journal
, vol.21
, pp. 1628-1637
-
-
Petaja-Repo, U.E.1
Hogue, M.2
Bhalla, S.3
Laperriere, A.4
Morello, J.P.5
-
77
-
-
0041854348
-
Membrane assembly of the cannabinoid receptor 1: Impact of a long N-terminal tail
-
Andersson H, D'Antona AM, Kendall DA, Von Heijne G, Chin CN, (2003) Membrane assembly of the cannabinoid receptor 1: Impact of a long N-terminal tail. Molecular Pharmacology 64: 570-577.
-
(2003)
Molecular Pharmacology
, vol.64
, pp. 570-577
-
-
Andersson, H.1
D'Antona, A.M.2
Kendall, D.A.3
Von Heijne, G.4
Chin, C.N.5
-
78
-
-
8744236215
-
Pharmacochaperones post-translationally enhance cell surface expression by increasing conformational stability of wild-type and mutant vasopressin V2 receptors
-
Wuller S, Wiesner B, Loffler A, Furkert J, Krause G, et al. (2004) Pharmacochaperones post-translationally enhance cell surface expression by increasing conformational stability of wild-type and mutant vasopressin V2 receptors. The Journal of Biological Chemistry 279: 47254-47263.
-
(2004)
The Journal of Biological Chemistry
, vol.279
, pp. 47254-47263
-
-
Wuller, S.1
Wiesner, B.2
Loffler, A.3
Furkert, J.4
Krause, G.5
-
79
-
-
0038147442
-
Endoplasmic reticulum retention, degradation, and aggregation of olfactory G-protein coupled receptors
-
Lu M, Echeverri F, Moyer BD, (2003) Endoplasmic reticulum retention, degradation, and aggregation of olfactory G-protein coupled receptors. Traffic (Copenhagen, Denmark) 4: 416-433.
-
(2003)
Traffic (Copenhagen, Denmark)
, vol.4
, pp. 416-433
-
-
Lu, M.1
Echeverri, F.2
Moyer, B.D.3
-
80
-
-
10144252497
-
Endoplasmic reticulum degradation impedes olfactory G-protein coupled receptor functional expression
-
Lu M, Staszewski L, Echeverri F, Xu H, Moyer BD, (2004) Endoplasmic reticulum degradation impedes olfactory G-protein coupled receptor functional expression. BMC Cell Biology 5: 34.
-
(2004)
BMC Cell Biology
, vol.5
, pp. 34
-
-
Lu, M.1
Staszewski, L.2
Echeverri, F.3
Xu, H.4
Moyer, B.D.5
-
81
-
-
33746730393
-
Effective inefficiency': Cellular control of protein trafficking as a mechanism of post-translational regulation
-
Conn PM, Janovick JA, Brothers SP, Knollman PE, (2006) 'Effective inefficiency': Cellular control of protein trafficking as a mechanism of post-translational regulation. The Journal of Endocrinology 190: 13-16.
-
(2006)
The Journal of Endocrinology
, vol.190
, pp. 13-16
-
-
Conn, P.M.1
Janovick, J.A.2
Brothers, S.P.3
Knollman, P.E.4
-
82
-
-
33750915929
-
Protein folding as posttranslational regulation: Evolution of a mechanism for controlled plasma membrane expression of a G protein-coupled receptor
-
Conn PM, Knollman PE, Brothers SP, Janovick JA, (2006) Protein folding as posttranslational regulation: Evolution of a mechanism for controlled plasma membrane expression of a G protein-coupled receptor. Molecular Endocrinology (Baltimore, Md.) 20: 3035-3041.
-
(2006)
Molecular Endocrinology (Baltimore, Md.)
, vol.20
, pp. 3035-3041
-
-
Conn, P.M.1
Knollman, P.E.2
Brothers, S.P.3
Janovick, J.A.4
-
83
-
-
0029588528
-
Differential glycosylation and intracellular trafficking for the long and short isoforms of the D2 dopamine receptor
-
Fishburn CS, Elazar Z, Fuchs S, (1995) Differential glycosylation and intracellular trafficking for the long and short isoforms of the D2 dopamine receptor. The Journal of Biological Chemistry 270: 29819-29824.
-
(1995)
The Journal of Biological Chemistry
, vol.270
, pp. 29819-29824
-
-
Fishburn, C.S.1
Elazar, Z.2
Fuchs, S.3
-
85
-
-
58249090329
-
Cell surface delivery and structural re-organization by pharmacological chaperones of an oligomerization-defective alpha(1b)-adrenoceptor mutant demonstrates membrane targeting of GPCR oligomers
-
Canals M, Lopez-Gimenez JF, Milligan G, (2009) Cell surface delivery and structural re-organization by pharmacological chaperones of an oligomerization-defective alpha(1b)-adrenoceptor mutant demonstrates membrane targeting of GPCR oligomers. The Biochemical Journal 417: 161-172.
-
(2009)
The Biochemical Journal
, vol.417
, pp. 161-172
-
-
Canals, M.1
Lopez-Gimenez, J.F.2
Milligan, G.3
-
86
-
-
84855295987
-
Prostaglandin D2 regulates joint inflammation and destruction in murine collagen-induced arthritis
-
Maicas N, Ibanez L, Alcaraz MJ, Ubeda A, Ferrandiz ML, (2012) Prostaglandin D2 regulates joint inflammation and destruction in murine collagen-induced arthritis. Arthritis and Rheumatism 64: 130-140.
-
(2012)
Arthritis and Rheumatism
, vol.64
, pp. 130-140
-
-
Maicas, N.1
Ibanez, L.2
Alcaraz, M.J.3
Ubeda, A.4
Ferrandiz, M.L.5
-
87
-
-
18844451476
-
In vitro coexpression and pharmacological rescue of mutant gonadotropin-releasing hormone receptors causing hypogonadotropic hypogonadism in humans expressing compound heterozygous alleles
-
Leanos-Miranda A, Ulloa-Aguirre A, Janovick JA, Conn PM, (2005) In vitro coexpression and pharmacological rescue of mutant gonadotropin-releasing hormone receptors causing hypogonadotropic hypogonadism in humans expressing compound heterozygous alleles. The Journal of Clinical Endocrinology and Metabolism 90: 3001-3008.
-
(2005)
The Journal of Clinical Endocrinology and Metabolism
, vol.90
, pp. 3001-3008
-
-
Leanos-Miranda, A.1
Ulloa-Aguirre, A.2
Janovick, J.A.3
Conn, P.M.4
-
88
-
-
77952333017
-
Pharmacochaperoning of the A1 adenosine receptor is contingent on the endoplasmic reticulum
-
Malaga-Dieguez L, Yang Q, Bauer J, Pankevych H, Freissmuth M, et al. (2010) Pharmacochaperoning of the A1 adenosine receptor is contingent on the endoplasmic reticulum. Molecular Pharmacology 77: 940-952.
-
(2010)
Molecular Pharmacology
, vol.77
, pp. 940-952
-
-
Malaga-Dieguez, L.1
Yang, Q.2
Bauer, J.3
Pankevych, H.4
Freissmuth, M.5
-
89
-
-
70349929579
-
Biased agonist pharmacochaperones of the AVP V2 receptor may treat congenital nephrogenic diabetes insipidus
-
Jean-Alphonse F, Perkovska S, Frantz MC, Durroux T, Mejean C, et al. (2009) Biased agonist pharmacochaperones of the AVP V2 receptor may treat congenital nephrogenic diabetes insipidus. Journal of the American Society of Nephrology: JASN 20: 2190-2203.
-
(2009)
Journal of the American Society of Nephrology: JASN
, vol.20
, pp. 2190-2203
-
-
Jean-Alphonse, F.1
Perkovska, S.2
Frantz, M.C.3
Durroux, T.4
Mejean, C.5
-
90
-
-
79955575162
-
International union of basic and clinical pharmacology. LXXXIII: Classification of prostanoid receptors, updating 15 years of progress
-
Woodward DF, Jones RL, Narumiya S, (2011) International union of basic and clinical pharmacology. LXXXIII: Classification of prostanoid receptors, updating 15 years of progress. Pharmacological Reviews 63: 471-538.
-
(2011)
Pharmacological Reviews
, vol.63
, pp. 471-538
-
-
Woodward, D.F.1
Jones, R.L.2
Narumiya, S.3
-
91
-
-
8844254704
-
Prostanoid DP1 receptor agonist inhibits the pruritic activity in NC/Nga mice with atopic dermatitis
-
Arai I, Takano N, Hashimoto Y, Futaki N, Sugimoto M, et al. (2004) Prostanoid DP1 receptor agonist inhibits the pruritic activity in NC/Nga mice with atopic dermatitis. European Journal of Pharmacology 505: 229-235.
-
(2004)
European Journal of Pharmacology
, vol.505
, pp. 229-235
-
-
Arai, I.1
Takano, N.2
Hashimoto, Y.3
Futaki, N.4
Sugimoto, M.5
-
92
-
-
33846089351
-
Effects of TS-022, a newly developed prostanoid DP1 receptor agonist, on experimental pruritus, cutaneous barrier disruptions and atopic dermatitis in mice
-
Arai I, Takaoka A, Hashimoto Y, Honma Y, Koizumi C, et al. (2007) Effects of TS-022, a newly developed prostanoid DP1 receptor agonist, on experimental pruritus, cutaneous barrier disruptions and atopic dermatitis in mice. European Journal of Pharmacology 556: 207-214.
-
(2007)
European Journal of Pharmacology
, vol.556
, pp. 207-214
-
-
Arai, I.1
Takaoka, A.2
Hashimoto, Y.3
Honma, Y.4
Koizumi, C.5
-
93
-
-
34250677710
-
The anti-pruritic efficacy of TS-022, a prostanoid DP1 receptor agonist, is dependent on the endogenous prostaglandin D2 level in the skin of NC/Nga mice
-
Sugimoto M, Arai I, Futaki N, Hashimoto Y, Sakurai T, et al. (2007) The anti-pruritic efficacy of TS-022, a prostanoid DP1 receptor agonist, is dependent on the endogenous prostaglandin D2 level in the skin of NC/Nga mice. European Journal of Pharmacology 564: 196-203.
-
(2007)
European Journal of Pharmacology
, vol.564
, pp. 196-203
-
-
Sugimoto, M.1
Arai, I.2
Futaki, N.3
Hashimoto, Y.4
Sakurai, T.5
-
94
-
-
33847143728
-
Activation of the D prostanoid 1 receptor suppresses asthma by modulation of lung dendritic cell function and induction of regulatory T cells
-
Hammad H, Kool M, Soullie T, Narumiya S, Trottein F, et al. (2007) Activation of the D prostanoid 1 receptor suppresses asthma by modulation of lung dendritic cell function and induction of regulatory T cells. The Journal of Experimental Medicine 204: 357-367.
-
(2007)
The Journal of Experimental Medicine
, vol.204
, pp. 357-367
-
-
Hammad, H.1
Kool, M.2
Soullie, T.3
Narumiya, S.4
Trottein, F.5
-
95
-
-
0034922462
-
Prevention of allergic inflammation by a novel prostaglandin receptor antagonist, S-5751
-
Arimura A, Yasui K, Kishino J, Asanuma F, Hasegawa H, et al. (2001) Prevention of allergic inflammation by a novel prostaglandin receptor antagonist, S-5751. The Journal of Pharmacology and Experimental Therapeutics 298: 411-419.
-
(2001)
The Journal of Pharmacology and Experimental Therapeutics
, vol.298
, pp. 411-419
-
-
Arimura, A.1
Yasui, K.2
Kishino, J.3
Asanuma, F.4
Hasegawa, H.5
-
96
-
-
84875507317
-
Anti-inflammatory role of PGD2 in acute lung inflammation and therapeutic application of its signal enhancement
-
Murata T, Aritake K, Tsubosaka Y, Maruyama T, Nakagawa T, et al. (2013) Anti-inflammatory role of PGD2 in acute lung inflammation and therapeutic application of its signal enhancement. Proceedings of the National Academy of Sciences USA 110: 5205-5210.
-
(2013)
Proceedings of the National Academy of Sciences USA
, vol.110
, pp. 5205-5210
-
-
Murata, T.1
Aritake, K.2
Tsubosaka, Y.3
Maruyama, T.4
Nakagawa, T.5
-
97
-
-
71749095907
-
Clinical studies of the DP1 antagonist laropiprant in asthma and allergic rhinitis
-
Philip G, van Adelsberg J, Loeys T, Liu N, Wong P, et al. (2009) Clinical studies of the DP1 antagonist laropiprant in asthma and allergic rhinitis. The Journal of Allergy and Clinical Immunology 124: 942-8.e1-9.
-
(2009)
The Journal of Allergy and Clinical Immunology
, vol.124
-
-
Philip, G.1
van Adelsberg, J.2
Loeys, T.3
Liu, N.4
Wong, P.5
|